Highly Qualified Advisors with Exceptional Track Records

Our board brings an unmatched depth of experience from the medical device and blood diagnostics marketplaces to provide guidance and oversight.

Board of Directors

Noubar Afeyan
CEO, Flagship Pioneering

John McDonough
CEO, Seventh Sense Biosystems

Thomas J. Cahill, MD, PhD
Founder and Managing Partner, Newpath Partners LLC

Marc Ceulemans
Head Strategic Venture Capital & Pharma Equities

Don Hardison
President, CEO and Director of Biotheranostics, Inc.

Peter Hutt, JD
Senior Counsel, Covington & Burling, LLP

Robert Langer, SCD
(Co-founder) Institute Professor, MIT

Harry Wilcox
General Partner, Flagship Pioneering

Easier access and better blood collection experiences change lives

The health information in blood is critical to fully-informed health decisions, but the blood-collection experiences available today fall short of making it as easy and accessible as it can be.

We’re striving to make sure that accessing whole blood samples does not prevent people from living the healthy lives they deserve.

A man holding a blood filled tube

The team at Seventh Sense is here to discuss how we can solve your needs:

200 Boston Avenue, Suite 3700
Medford, MA 02155 USA

Remote Self-Collected Whole Blood with an FDA Cleared Device

Seventh Sense designs and develops push-button blood collection devices that make the blood collection process simple, convenient, and more comfortable.

Everyone deserves a healthy life with easy access to healthcare.​
© 2021, Seventh Sense Biosystems. All rights reserved.